DEXTROSE- dextrose monohydrate injection, solution

Land: Verenigde Staten

Taal: Engels

Bron: NLM (National Library of Medicine)

Werkstoffen:

DEXTROSE MONOHYDRATE (UNII: LX22YL083G) (ANHYDROUS DEXTROSE - UNII:5SL0G7R0OK)

Beschikbaar vanaf:

Hospira, Inc.

Toedieningsweg:

INTRAVENOUS

Prescription-type:

PRESCRIPTION DRUG

therapeutische indicaties:

50% Dextrose Injection is indicated in the treatment of insulin hypoglycemia (hyperinsulinemia or insulin shock) to restore blood glucose levels. The solution is also indicated, after dilution, for intravenous infusion as a source of carbohydrate calories in patients whose oral intake is restricted or inadequate to maintain nutritional requirements. Slow infusion of hypertonic solutions is essential to ensure proper utilization of dextrose and avoid production of hyperglycemia. A concentrated dextrose solution should not be used when intracranial or intraspinal hemorrhage is present, nor in the presence of delirium tremens if the patient is already dehydrated. Dextrose injection without electrolytes should not be administered simultaneously with blood through the same infusion set because of the possibility that pseudoagglutination of red cells may occur.

Product samenvatting:

50% Dextrose Injection, USP is supplied in single-dose containers as follows: Bundle of 10 50 mL LifeShield® Abboject® Unit of Use Syringe with Male Luer Lock adapter and protected needle 25 g/50 mL (0.5 g/mL) 0409-4902-34 Bundle of 10 50 mL Single-Dose Abboject® Syringe with Male Luer Lock Adapter 25 g/50 mL (0.5 g/mL) 0409-0505-25 Tray of 25 50 mL Single-Dose Fliptop Vials 25 g/50 mL (0.5 g/mL) 0409-6648-02 Bundle of 10 50 mL Ansyr® II Plastic Syringe with syringe and barrel detached 25 g/50 mL (0.5 g/mL) 0409-7517-16 Exposure of pharmaceutical products to heat should be minimized. Avoid excessive heat. Protect from freezing. Store at 20 to 25°C (68 to 77°F). [See USP Controlled Room Temperature.]

Autorisatie-status:

New Drug Application

Productkenmerken

DEXTROSE- DEXTROSE MONOHYDRATE INJECTION, SOLUTION
HOSPIRA, INC.
----------
50% DEXTROSE INJECTION, USP
CONCENTRATED DEXTROSE FOR
INTRAVENOUS ADMINISTRATION
NOTE: THIS SOLUTION IS HYPERTONIC - SEE WARNINGS AND PRECAUTIONS.
LIFESHIELD ABBOJECT SYRINGE
ABBOJECT SYRINGE
FLIPTOP CONTAINER
ANSYR II PLASTIC SYRINGE
Rx only
DESCRIPTION
50% Dextrose Injection, USP is a sterile, nonpyrogenic, hypertonic
solution of dextrose
in water for injection for intravenous injection as a fluid and
nutrient replenisher.
Each mL of fluid contains 0.5 g dextrose, hydrous which delivers 3.4
kcal/gram. The
solution has an osmolarity of 2.53 mOsmol/mL (calc.), pH 3.2 to 6.5
and may contain
sodium hydroxide and/or hydrochloric acid for pH adjustment.
The solution contains no bacteriostat, antimicrobial agent or added
buffer (except for pH
adjustment) and is intended only for use as a single-dose injection.
When smaller doses
are required, the unused portion should be discarded with the entire
unit.
Dextrose, USP is chemically designated C H
O ∙ H O (D-glucose monohydrate), a
hexose sugar freely soluble in water.
Dextrose, hydrous has the following structural formula:
Water for Injection, USP is chemically designated H O.
The syringe is molded from a specially formulated polypropylene. Water
permeates from
inside the container at an extremely slow rate which will have an
insignificant effect on
®
®
®
®
6
12
6
2
2
solution concentration over the expected shelf life. Solutions in
contact with the plastic
container may leach out certain chemical components from the plastic
in very small
amounts; however, biological testing was supportive of the safety of
the syringe
material.
CLINICAL PHARMACOLOGY
When administered intravenously this solution restores blood glucose
levels in
hypoglycemia and provides a source of carbohydrate calories.
Carbohydrate in the form of dextrose may aid in minimizing liver
glycogen depletion and
exerts a protein-sparing action. Dextrose injection undergoes
oxidation to carbon
dioxide and water.
Water is an essen